The earlier report suggests that the chimeric anti-CD20 mAb (Rtx) and cross-linking Fab'2 fragment, on B-cell chronic lymphocytic leukaemia cells (B-CLL) induce apoptosis through p38 MAP-kinase activation [21]. This evidence concerns the gene MAPK14 and B-cell chronic lymphocytic leukemia.